SV Health Investors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

SV Health Investors’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,956,456	Closed	-$72.1M	–	8
2017 Q4	$72.1M	Hold	2,956,456	–	–	38.09%	1
2017 Q3	$54.6M	Hold	2,956,456	–	–	41.39%	1
2017 Q2	$49M	Hold	2,956,456	–	–	52.7%	1
2017 Q1	$40.8M	Sell	2,956,456 -533,077	-15%	-$8.56M	45.06%	1
2016 Q4	$66.2M	Hold	3,489,533	–	–	55.74%	1
2016 Q3	$77.4M	Hold	3,489,533	–	–	59.45%	1
2016 Q2	$63.8M	Hold	3,489,533	–	–	64.37%	1
2016 Q1	$63.5M	Hold	3,489,533	–	–	47.43%	1
2015 Q4	$58.8M	Hold	3,489,533	–	–	47.3%	1
2015 Q3	$62.9M	Hold	3,489,533	–	–	35.17%	1
2015 Q2	$90.3M	Hold	3,489,533	–	–	34.56%	1
2015 Q1	$76.4M	Buy	+3,489,533	New	+$75.3M	25.25%	3

SV Health Investors's ENTL Position: Q1 2018 in Review

SV Health Investors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 2,956,456 shares — an estimated $72.1M sold.

SV Health Investors first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $90.3M in Q2 2015. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

SV Health Investors reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
SV Health Investors sold 2,956,456 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $72.1M.
SV Health Investors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
SV Health Investors's Entellus Medical, Inc. Common Stock position peaked at $90.3M in Q2 2015.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on SV Health Investors's 13F filing for Q1 2018, filed 15 May 2018.